Laboratory Historical Financial Ratios
| LH Stock | USD 241.16 0.99 0.41% |
Laboratory is lately reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 67.82, Book Value Per Share of 95.12 or Free Cash Flow Yield of 0.0591 will help investors to properly organize and evaluate Laboratory financial condition quickly.
Laboratory |
About Laboratory Financial Ratios Analysis
LaboratoryFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Laboratory investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Laboratory financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Laboratory history.
Laboratory Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is Laboratory of dividend as a percentage of Laboratory stock price. Laboratory dividend yield is a measure of Laboratory stock productivity, which can be interpreted as interest rate earned on an Laboratory investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Research And Ddevelopement To Revenue
The ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services.Most ratios from Laboratory's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Laboratory's Free Cash Flow Yield is decreasing as compared to previous years. The Laboratory's current Operating Cash Flow Per Share is estimated to increase to 16.01, while Price To Sales Ratio is projected to decrease to 1.57.
| 2023 | 2024 (projected) | Dividend Yield | 0.0128 | 0.0122 | Price To Sales Ratio | 1.63 | 1.57 |
Laboratory fundamentals Correlations
Click cells to compare fundamentals
Laboratory Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Laboratory fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 1.88 | 1.82 | 2.54 | 1.83 | 2.51 | 3.28 | |
| Days Sales Outstanding | 63.98 | 78.77 | 67.43 | 49.0 | 62.99 | 67.82 | |
| Book Value Per Share | 77.29 | 96.19 | 106.23 | 110.83 | 90.59 | 95.12 | |
| Free Cash Flow Yield | 0.0841 | 0.0734 | 0.1 | 0.08 | 0.0442 | 0.0591 | |
| Operating Cash Flow Per Share | 14.76 | 21.95 | 32.16 | 21.47 | 15.24 | 16.01 | |
| Stock Based Compensation To Revenue | 0.00926 | 0.007991 | 0.008244 | 0.007851 | 0.0106 | 0.009973 | |
| Pb Ratio | 1.88 | 1.82 | 2.54 | 1.83 | 2.51 | 3.28 | |
| Free Cash Flow Per Share | 10.67 | 18.02 | 27.4 | 16.18 | 10.04 | 10.54 | |
| Inventory Turnover | 33.93 | 21.33 | 26.15 | 22.29 | 18.53 | 31.7 | |
| Net Income Per Share | 8.41 | 15.99 | 24.58 | 14.04 | 4.8 | 3.85 | |
| Days Of Inventory On Hand | 10.76 | 17.11 | 13.96 | 16.37 | 19.69 | 10.43 | |
| Payables Turnover | 13.13 | 14.13 | 16.89 | 12.31 | 10.63 | 16.73 | |
| Capex To Revenue | 0.0346 | 0.0273 | 0.0286 | 0.0324 | 0.0373 | 0.0387 | |
| Cash Per Share | 3.54 | 13.57 | 15.34 | 4.72 | 6.16 | 6.47 | |
| Pocfratio | 9.85 | 7.97 | 8.39 | 9.42 | 14.91 | 12.4 | |
| Interest Coverage | 5.53 | 11.79 | 15.37 | 9.84 | 3.64 | 3.45 | |
| Pfcf Ratio | 13.62 | 9.7 | 9.85 | 12.5 | 22.65 | 23.78 | |
| Days Payables Outstanding | 27.8 | 25.84 | 21.6 | 29.65 | 34.34 | 20.38 | |
| Income Quality | 1.75 | 1.37 | 1.31 | 1.53 | 3.49 | 3.66 | |
| Ev To Operating Cash Flow | 14.52 | 10.51 | 9.96 | 12.42 | 18.99 | 16.63 | |
| Pe Ratio | 17.27 | 10.93 | 10.98 | 14.41 | 47.36 | 49.73 | |
| Ev To Free Cash Flow | 20.08 | 12.8 | 11.69 | 16.48 | 28.85 | 30.29 | |
| Earnings Yield | 0.0579 | 0.0915 | 0.0911 | 0.0694 | 0.0211 | 0.0344 | |
| Net Debt To E B I T D A | 3.19 | 1.67 | 1.14 | 3.0 | 4.03 | 3.39 | |
| Current Ratio | 1.13 | 1.66 | 1.92 | 1.5 | 1.17 | 1.76 | |
| Tangible Book Value Per Share | (44.25) | (24.18) | (14.7) | (21.64) | (18.3) | (19.22) | |
| Receivables Turnover | 5.71 | 4.63 | 5.41 | 7.45 | 5.79 | 5.02 | |
| Graham Number | 120.97 | 186.05 | 242.41 | 187.12 | 98.81 | 103.75 | |
| Shareholders Equity Per Share | 77.29 | 96.19 | 106.23 | 110.83 | 90.41 | 94.93 |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.